Kenvue is a new consumer health company built on over a century of heritage and propelled forward by science.
Kenvue wanted help introducing the company to investors for IPO listing day on the New York Stock Exchange in May 2023. The campaign celebrated their iconic brands like Johnson’s®, Listerine®, Neutrogena®, Tylenol®, and more, which are recommended by healthcare professionals and used by millions of people around the world. The project goal was to succinctly channel the company's intent purpose, story, and visual identity into a strong first impression to investors.
Using the new visual identity and brand photography developed by brand consultancy Wolff Olins and photographer Bobby Doherty, we worked with Kenvue’s corporate brand team to help lead the campaign creative. We lead the overarching messaging development, design and animation across out of home, online, social and print media. Consistent messaging, portfolio photography and dynamic compositions brought the brand to life with care and confidence in diverse contexts.